Daniel Motto
Operationeel Directeur bij Enalare Therapeutics, Inc.
Profiel
Daniel Motto is currently the Chief Operating Officer at Enalare Therapeutics, Inc. Prior to his current position, he worked at Allergan Ltd.
(Ireland) from 2010 to 2016 as the SVP-Business Development & Portfolio Management.
Actieve functies van Daniel Motto
Bedrijven | Functie | Begin |
---|---|---|
Enalare Therapeutics, Inc.
Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | Operationeel Directeur | - |
Eerdere bekende functies van Daniel Motto
Bedrijven | Functie | Einde |
---|---|---|
ALLERGAN PLC | Corporate Officer/Principal | 01-08-2016 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Enalare Therapeutics, Inc.
Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | Commercial Services |